Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Nadia K. Waheed, MD, MPH, Appointed Chief Medical Officer; Peter K. Kaiser, MD, to Become Chief Development Officer; Andrea Gibson, PhD, Named Vice
Pioneering Medical Innovations
Nadia K. Waheed, MD, MPH, Appointed Chief Medical Officer; Peter K. Kaiser, MD, to Become Chief Development Officer; Andrea Gibson, PhD, Named Vice
BEDFORD, Mass., April 15, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of
Life Sciences Voice recently announced their “Top Industry Leaders Awards” for 2023, which honors visionary executives propelling the life sciences industry forward
Industry Leader and Retina Expert, Pravin U. Dugel, MD, Becomes Executive Chair Jeffrey S. Heier, MD to become Chief Scientific
Strategic promotion underscores commitment to commercial growth across Ocular portfolio BEDFORD, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical
Chuck Alpuche Appointed as COO, Peter Griffin as SVP of Operations, Scott Elliott as CLO, Daniel Davis as CSO Seasoned
Imperative Care has announced a new organizational structure designed to accelerate the company’s growth across its businesses. According to an
Kirsten Carroll appointed CEO; Stefan Heuser named CFO and Clayton Duncan named SVP, Commercialization Kandu Health achieves successful enrollment of
Petrovic brings significant leadership in the global medical technology sector June 06, 2023 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS
Sutton to Continue to Drive Company’s Leadership in Highly Competitive Stroke Market. CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company